These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


607 related items for PubMed ID: 19747492

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Immunotherapy of type 1 diabetes--how to rationally prioritize combination therapies in T1D.
    Boettler T, von Herrath M.
    Int Immunopharmacol; 2010 Dec; 10(12):1491-5. PubMed ID: 20667487
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. New type of human blood stem cell: a double-edged sword for the treatment of type 1 diabetes.
    Zhao Y, Lin B, Dingeldein M, Guo C, Hwang D, Holterman MJ.
    Transl Res; 2010 May; 155(5):211-6. PubMed ID: 20403575
    [Abstract] [Full Text] [Related]

  • 6. Immunotherapy for the prevention and treatment of type 1 diabetes.
    Goudy KS, Tisch R.
    Int Rev Immunol; 2005 May; 24(5-6):307-26. PubMed ID: 16318984
    [Abstract] [Full Text] [Related]

  • 7. Beta-cell replacement for insulin-dependent diabetes mellitus.
    Efrat S.
    Adv Drug Deliv Rev; 2008 Jan 14; 60(2):114-23. PubMed ID: 18022276
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Plasmacytoid dendritic cells in autoimmune diabetes - potential tools for immunotherapy.
    Nikolic T, Welzen-Coppens JM, Leenen PJ, Drexhage HA, Versnel MA.
    Immunobiology; 2009 Jan 14; 214(9-10):791-9. PubMed ID: 19628297
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Are stem cells a cure for diabetes?
    McCall MD, Toso C, Baetge EE, Shapiro AM.
    Clin Sci (Lond); 2009 Oct 12; 118(2):87-97. PubMed ID: 19807695
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pluripotent stem cells, a potential source of beta-cells for diabetes therapy.
    Hansson M, Madsen OD.
    Curr Opin Investig Drugs; 2010 Apr 12; 11(4):417-25. PubMed ID: 20336589
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The role of low avidity T cells in the protection against type 1 diabetes: a modeling investigation.
    Khadra A, Santamaria P, Edelstein-Keshet L.
    J Theor Biol; 2009 Jan 07; 256(1):126-41. PubMed ID: 18950644
    [Abstract] [Full Text] [Related]

  • 19. Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes.
    Vija L, Farge D, Gautier JF, Vexiau P, Dumitrache C, Bourgarit A, Verrecchia F, Larghero J.
    Diabetes Metab; 2009 Apr 07; 35(2):85-93. PubMed ID: 19230736
    [Abstract] [Full Text] [Related]

  • 20. The potential role of dendritic cells in the therapy of Type 1 diabetes.
    Lee CN, Lew AM, Wu L.
    Immunotherapy; 2013 Jun 07; 5(6):591-606. PubMed ID: 23725283
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 31.